Cerecor raises $26M in a downsized IPO to fund its depression pipeline

Baltimore biotech Cerecor ($CERCU) raised $26 million in an IPO to bankroll its work on treatments for depression, issuing warrants to bring in the cash it needs. Cerecor priced 4 million units at $6.50 apiece, with each unit including one share of common stock, one warrant to purchase another share and a second warrant redeemable for a half share. With the proceeds, Cerecor is advancing three therapies for major depressive disorder, with two in Phase II and another in preclinical development. Release